Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus
ObjectiveThis study aimed to investigate the risk factors for multidrug resistance (MDR) in patients with pulmonary tuberculosis (PTB) and diabetes mellitus (DM), including those with and without prior TB treatment.MethodsA retrospective study was conducted from 1 January 2021, to 31 December 2023,...
Saved in:
Main Authors: | Lianpeng Wu, Na Chen, Dandan Xia, Xiangao Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1516207/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review
by: Denise Rossato Silva, et al.
Published: (2025-01-01) -
Multidrug Resistance Tuberculosis in the Context of Co-Infection in Ethiopia: A Systematic Review and Meta-Analysis
by: Bezawit Kassaw Hailu, et al.
Published: (2025-02-01) -
Urban-rural difference in adverse outcomes of pulmonary tuberculosis in patients with pulmonary tuberculosis-diabetes mellitus comorbidity
by: FANG Zijian, LI Qingchun,XIE Li,SONG Xu,DAI Ruoqi,WU Yifei,JIA Qingjun,CHENG Qinglin
Published: (2025-01-01) -
Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China
by: Liqing Wei, et al.
Published: (2025-01-01) -
Vitamin D Deficiency in Patients with Type 2 Diabetes Mellitus with and without Pulmonary Tuberculosis
by: Wahiduddin Wahiduddin, et al.
Published: (2024-11-01)